Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. circulatory support
Show results for
Products
Services

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Circulatory Support Articles & Analysis

41 news found

Puzzle Medical to Present at AHA 2022 its First-in-Human Study Results

Puzzle Medical to Present at AHA 2022 its First-in-Human Study Results

(PMD) developed a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure (HF). PMD announced it will present its first-in-human results for the ModulHeartTM in the following session during the American Heart Association (AHA) meeting held November 5–7, 2022 at the McCormick Place Convention Center in Chicago, IL: ...

ByPuzzle Medical Devices Inc.


Puzzle Medical Devices Inc. Wins TCT 2022 Shark Tank Innovation Competition

Puzzle Medical Devices Inc. Wins TCT 2022 Shark Tank Innovation Competition

The Cardiovascular Research Foundation (CRF) is pleased to announce that Puzzle Medical Devices Inc. has won the TCT 2022 Shark Tank Innovation Competition for its novel circulatory support device that is implanted percutaneously in the abdominal aorta. ...

ByPuzzle Medical Devices Inc.


Puzzle Medical to Present at TCT 2022 Its First-in-Human Study Results for the ModulHeart™

Puzzle Medical to Present at TCT 2022 Its First-in-Human Study Results for the ModulHeart™

(PMD) developed a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure (HF). ...

ByPuzzle Medical Devices Inc.


Puzzle Medical Announces the Successful Completion of its First-in-Human Study with its ModulHeart

Puzzle Medical Announces the Successful Completion of its First-in-Human Study with its ModulHeart

Four patients had ModulHeart deployed to provide circulatory support while undergoing high-risk percutaneous coronary intervention (PCI) procedures. ...

ByPuzzle Medical Devices Inc.


Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System

Jorde, MD, professor of medicine, Albert Einstein College of Medicine, and section head of Heart Failure, Cardiac Transplantation and Mechanical Circulatory Support at Montefiore Health System in New York, and global co-principal investigator of the CORCINCH-HF ...

ByAncora Heart, Inc


Saranas Recognized as One of Houston’s Most Innovative Companies

Saranas Recognized as One of Houston’s Most Innovative Companies

One in five patients experience a bleeding complication during large-bore endovascular procedures such as transcatheter aortic valve replacement (TAVR), endovascular aneurysm repair (EVAR) and percutaneous mechanical circulatory support. The Early Bird is the first and only device for real-time detection and monitoring of these types of complications. ...

BySaranas, Inc.


Supira Medical, A Shifamed Portfolio Company, Closes $30m in an Oversubscribed Series C Financing

Supira Medical, A Shifamed Portfolio Company, Closes $30m in an Oversubscribed Series C Financing

Company to Advance its Next Generation Percutaneous Ventricular Assist Device Los Gatos, Calif., February 28, 2022 – Supira Medical, Inc., a Shifamed portfolio company that is focused on developing a next-generation solution for temporary mechanical circulatory support, announced today the closing of $30M in Series C financing. ...

BySupira Medical


4Q 2021 Stakeholder Update

4Q 2021 Stakeholder Update

We believe we are set now to begin a cardio-renal syndrome clinical study with 24 hours circulatory assist support time in 1Q 2022. Our team believes we are in the front leadership position in the industry in transitioning to wireless power with tremendous progress made in building and testing wireless powered prototypes achieved in 2021. ...

BySecond Heart Assist, Inc.


Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study

Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study

PA pressure-guided heart failure management is quickly becoming standard of care for NYHA class III patients based on the growing body of evidence supporting this approach,” commented Dr. Liviu Klein, Section Chief, Advanced Heart Failure, Mechanical Circulatory Support, Pulmonary Hypertension and Heart Transplant at UCSF and National ...

ByEndotronix, Inc.


Saranas® Announces Initial Enrollment of Clinical Trial Assessing the Utility of Early Bleed Detection in Patients Undergoing Mechanical Circulatory Support

Saranas® Announces Initial Enrollment of Clinical Trial Assessing the Utility of Early Bleed Detection in Patients Undergoing Mechanical Circulatory Support

Saranas, Inc., has announced initiation and first patient enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of complex high-risk percutaneous coronary intervention (PCI) using mechanical circulatory support (MCS) and surveillance with the Early Bird Bleed Monitoring System. ...

BySaranas, Inc.


CARMAT announces the first implant of its Aeson total artificial heart in The Netherlands

CARMAT announces the first implant of its Aeson total artificial heart in The Netherlands

It was the first time ever that atotalartificial heart was implanted in The Netherlands.UMC Utrechtisone of the three heart transplantation centers in the countryandthe most experienced Mechanical Circulatory Support (MCS) center, having implanted the first MCS in the countryin 1993. ...

ByCarmat


Orchestra BioMed Announces Presentations at TCT 2021 of Positive Long-Term Clinical Results from the MODERATO II Study Showing the Significant Clinical Impact of BackBeat CNT on Isolated Systolic Hypertension and Pulse Pressure

Orchestra BioMed Announces Presentations at TCT 2021 of Positive Long-Term Clinical Results from the MODERATO II Study Showing the Significant Clinical Impact of BackBeat CNT on Isolated Systolic Hypertension and Pulse Pressure

“We are very encouraged by the exploratory findings highlighting BackBeat CNT’s impact in patients with ISH, particularly since a substantial reduction in Pulse Pressure can dramatically lower overall cardiovascular risk,” said Daniel Burkhoff, M.D., Ph.D., Director of Heart Failure, Hemodynamics and Mechanical Circulatory Support Research at ...

ByOrchestra BioMed, Inc.


Procyrion’S Aortix Percutaneous Mechanical Circulatory Support Device to be Showcased at Tct 2021 Annual Meeting

Procyrion’S Aortix Percutaneous Mechanical Circulatory Support Device to be Showcased at Tct 2021 Annual Meeting

The series of presentations highlights the Aortix percutaneous intra-aortic mechanical circulatory support device, which is a platform technology in development that will initially target treatment of CRS patients. ...

ByProcyrion, Inc.


CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up

CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up

During his career, he has worked on the process development and manufacturing of two different companies in the mechanical circulatory support space. These efforts contributed to the support of over 18,000 heart failure patients around the world. ...

ByCorWave


CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device

CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device

The final results of the 60-day experience, presented at the ESAO conference, confirm the CorWave pump’s ability to provide chronic circulatory support with outstanding hemocompatibility. Dr. Snyder explained, “We were thrilled by the performance of the pump. ...

ByCorWave


Berlin Heart Received CE Mark and Announces First Implantation of the Latest Cannula Generation to Treat Heart Patients Waiting for a Donor Heart

Berlin Heart Received CE Mark and Announces First Implantation of the Latest Cannula Generation to Treat Heart Patients Waiting for a Donor Heart

Berlin, September 2021: Berlin Heart today announces the CE mark and first implantation of an innovative outflow cannula for mechanical circulatory support with the paracorporeal pulsatile EXCOR® ventricular assist device. ...

ByBerlin Heart GmbH


CARMAT announces a new commercial implant of its Aeson artificial heart at University Medical Center Schleswig-Holstein in Kiel, Germany

CARMAT announces a new commercial implant of its Aeson artificial heart at University Medical Center Schleswig-Holstein in Kiel, Germany

Assad Haneya, Director of the Transplantation and Mechanical Circulatory Support Program at UKSH, declared: “We are pleased to have successfully implanted the CARMAT TAH in our center last week. ...

ByCarmat


CARMAT announces the second center implanting its total artificial heart in the United States

CARMAT announces the second center implanting its total artificial heart in the United States

UofL Health and the University of Louisville are known for ground-breaking cardiovascular innovation research, especially in circulatory support technologies. Jewish Hospital is the second U.S. hospital to implant Aeson® within the framework of the EFS. ...

ByCarmat


First human implant of the Aeson artificial heart in Germany

First human implant of the Aeson artificial heart in Germany

Schmitto, Director of the Mechanical Circulatory Support and Cardiac Transplantation Program at Hannover Medical School, declared: “The implant of the first CARMAT TAH in Germany represents another milestone in the field of Mechanical Circulatory Support Devices. ...

ByCarmat


Berlin Heart triples staff member donations and secures `Films for life` project financing

Berlin Heart triples staff member donations and secures `Films for life` project financing

About Berlin Heart Berlin Heart GmbH develops, manufactures, and markets innovative ventricular assist devices (VADs) for mechanical circulatory support. With the EXCOR® Adult and the EXCOR® Pediatric, Berlin Heart is the only company in the world able to provide support to patients of every age and size, from infants to adults, thereby ...

ByBerlin Heart GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT